Phare Bio Inc

Medical research organization based in Boston, MA. 3 employees. Exempt under §501(c)(3).

MissionPHARE BIO'S MISSION IS TO DEVELOP CRITICALLY NEEDED ANTIBIOTICS TO ADDRESS A LOOMING CRISIS IN ANTIBIOTIC RESISTANCE. USING NOVEL AI AND DEEP LEARNING APPROACHES, PHARE BIO AIMS TO RAPIDLY DISCOVER AND DEVELOP NEW CLASSES OF ANTIBIOTICS AGAINST THE DEADLIEST PATHOGENS, AND ENSURE

EIN
85-1085804
State
MA
Sector
Medical research
Budget band
$1M–$2.5M
Latest filing
TY 2023
Records
2 officers · 4 years

Financial snapshot · TY 2023

$2.1M
Total revenue
$1.5M
Total expenses
$2.6M
Net assets

Financial health · TY 2023

65
Moderate financial health
Composite score out of 100 based on reserve ratio, program efficiency, and revenue diversification.
Reserve ratio
100
20.6 months of expenses
Program efficiency
63
75.1% spent on programs
Revenue diversity
0
Mix of program fees, grants & contributions

Leadership compensation

Akhila Kosaraju
CEO & PRESIDENT
$563,402
100th percentile vs. peers
Claire Nishioka Robinson
SENIOR DIRECTOR, BUSINESS STRATEGIES
$167,217
79th percentile vs. peers

Is this your organization?

Claim this page for a private dashboard with financial health, peer benchmarks, and comp history.

Claim this page
Phare Bio Inc Executive Compensation | 990 Data | DoubleNine